Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2003
11/26/2003CN1458931A Tartrate salts of thiazolidinedione derivative
11/26/2003CN1458930A Tartrate salts of thiazolidinedione derivative
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458843A Aotomatic controlling nurve regulator and its health drinks and foods
11/26/2003CN1458840A Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/26/2003CN1458163A Oriental waterplantain rhizome sterol extract and its preparing method and quality control method
11/26/2003CN1458161A Process for producing human insulin using transgenic tomato
11/26/2003CN1458158A Biphosphonate
11/26/2003CN1457862A Paste for treating cardio-cerebral vascular diseases, hepatitis and ruducing blood fat and blood pressure
11/26/2003CN1457835A Draqon's blood dripping pill for removing blood stasis and killing pain, arresting bleeding and promoting granulation and its preparing method
11/26/2003CN1457807A Medicine for curing diabetes
11/26/2003CN1457800A Formula of anti-senility tablet and preparing method
11/26/2003CN1457792A Process for producing fat reducing medicine
11/26/2003CN1457791A Process for producing body slimming drink
11/26/2003CN1457786A Composition for curing hyperlipemia
11/26/2003CN1457775A Composition containing dihydro myricitrin and myricitrin
11/26/2003CN1457774A Use of ampelopsin for preparing blood sugar reducing medicine
11/26/2003CN1457773A Biguanide vanadium complex granular powder and/or capsule for curing diabetes and its use
11/26/2003CN1457688A Brain strengthening chewing tablet for child
11/26/2003CN1457670A Slowly digestable starch product
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/26/2003CN1128623C Instant effervescent particles for Ca-supplementing health-care products and its preparing process
11/26/2003CN1128615C Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
11/25/2003US6653334 Benzoxazole compound and pharmaceutical composition containing the same
11/25/2003US6653332 Combination therapeutic compositions and method of use
11/25/2003US6653321 Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653094 Diagnosing pancreatic defect in humans; obtain organelle sample, detect preferential organelle, monitor sample for organelle defect, diagnose pancreatic defect
11/25/2003US6652885 Complexing drug with diketopiperazine; washing; separation of impurities
11/25/2003US6652881 Micronized, quick dissolving; water, polysorbate 80 and sodium lauryl sulfate
11/25/2003US6652865 For decreasing the effect of intestinal metabolism on a drug
11/25/2003CA2163028C New thiazolidinediones and pharmaceutical agents containing them
11/25/2003CA2134679C Soluble analogs of probucol
11/25/2003CA2117305C Substituted imidazole derivatives and their preparation and use
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095667A2 Autoimmune conditions and nadph oxidase defects
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095607A2 Role of p62 in aging-related disease
11/20/2003WO2003095485A2 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095432A1 Benzimidazole derivatives
11/20/2003WO2003095428A1 Dopamine receptor modulators as antipsychotic agents
11/20/2003WO2003095425A1 Cyanopyrrolidine derivatives
11/20/2003WO2003095421A1 Amino acid analogues
11/20/2003WO2003094991A1 Medical products comprising a haemocompatible coating, production and use thereof
11/20/2003WO2003094990A1 Compounds and method for coating surfaces in a haemocompatible manner
11/20/2003WO2003094951A1 Soluble formulations comprising insulin aspart and insulin detemir
11/20/2003WO2003094946A1 Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid
11/20/2003WO2003094942A1 Soluble composition containing sporopollenin and the use thereof
11/20/2003WO2003094933A2 Use of lanthanum for the treatment of hypercalcemia and bone metastasis
11/20/2003WO2003094928A1 Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels
11/20/2003WO2003094927A1 Method of inhibiting d-glucose absorption and d-glucose absorption inhibitor
11/20/2003WO2003094923A1 COMBINATION OF AN HMG-CoA REDUCTASE INHIBITOR AND A NITRATE ESTER
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094915A1 Use of valsartan ot its metabolite to inhibit platelet aggregation
11/20/2003WO2003094912A1 Bislactone derivative and use thereof in medicinal composition
11/20/2003WO2003094911A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
11/20/2003WO2003094897A1 Photostabilized soft capsule
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094831A2 Novel diazabicyclic biaryl derivatives
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003053352A3 Therapeutic compounds for treating dyslipidemic conditions
11/20/2003WO2003050504A3 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
11/20/2003WO2003049752A3 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
11/20/2003WO2003048130A3 Peroxisome proliferator activated receptor agonists
11/20/2003WO2003045993A3 Protein biopolymer markers predictive of type ii diabetes
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003029210A3 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/20/2003WO2003027076A3 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/20/2003WO2003023018A3 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
11/20/2003WO2003022804A3 Method for the preparation of crystalline tetrahydrobenzothiepines
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003013512A3 Crystalline forms of fluvastatin sodium
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002072146A3 Combination of nateglinide or repaglinide with at least one further antidiabetic compound
11/20/2003WO2002070698A3 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity
11/20/2003WO2002058731A3 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003US20030217379 Defective tyrosine phosphatase animal model for diagnosing and treating diabetes and eating disorders
11/20/2003US20030216574 Pyrazine based inhibitors of glycogen synthase kinase 3
11/20/2003US20030216542 Modified insulin for delivery to lungs by breathing and treatment of diabetes
11/20/2003US20030216481 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse
1 ... 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 ... 1298